Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00117715 · ClinicalTrials.gov registry record
Developmental Regulation of Proteins Responsible for Transforming Drugs in the Body
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 121
- Enrollment target
NCT00117715 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 121 participants.
The verdict
NCT00117715 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 121 participants
- Enrollment target
Study Summary
This is a drug metabolism study in one-year old children involving caffeine and dextromethorphan.
Interventions
- PROCEDURE Genotyping and Phenotyping using dextromethorphan and caffeine as probes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2000-10 |
| Est. Completion | 2010-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00117715
The ClinicalTrials.gov registry entry for NCT00117715 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genotyping and Phenotyping using dextromethorphan and caffeine as probes is the first listed.
NCT00117715 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00117715 about?
NCT00117715 is a clinical study titled "Developmental Regulation of Proteins Responsible for Transforming Drugs in the Body". This is a drug metabolism study in one-year old children involving caffeine and dextromethorphan.
What is the current status of trial NCT00117715?
This trial is currently completed. The enrollment target is 121 participants. The study started on 2000-10. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00117715?
The interventions under investigation include: Genotyping and Phenotyping using dextromethorphan and caffeine as probes (PROCEDURE).
Who is sponsoring clinical trial NCT00117715?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.